NYSE:HTA - Healthcare Trust of America Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $29.70
  • Forecasted Upside: 3.13 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$28.80
▲ +0.6 (2.13%)
1 month | 3 months | 12 months
Get New Healthcare Trust of America Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HTA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HTA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$29.70
▲ +3.13% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Healthcare Trust of America in the last 3 months. The average price target is $29.70, with a high forecast of $38.00 and a low forecast of $24.00. The average price target represents a 3.13% upside from the last price of $28.80.
Buy
The current consensus among 13 investment analysts is to buy stock in Healthcare Trust of America. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 5 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/30/2019
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
10/28/2019
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/21/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings
1/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/20/2021Capital One FinancialDowngradeOverweight ➝ Equal WeightLow
i
1/13/2021Jefferies Financial GroupBoost Price TargetBuy$33.00 ➝ $35.00High
i
12/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$29.00Low
i
12/15/2020Smith Barney CitigroupUpgradeNeutral ➝ BuyLow
i
12/15/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellUpgradeNeutral ➝ Buy$28.00 ➝ $29.00Medium
i
9/1/2020Stifel NicolausReiterated RatingBuy$32.00Medium
i
8/31/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$29.00Low
i
7/2/2020CitigroupBoost Price TargetNeutral$25.00 ➝ $28.00Low
i
5/6/2020BMO Capital MarketsReiterated RatingBuy$38.00Medium
i
Rating by John Kim at BMO Capital Markets
4/23/2020SunTrust BanksLower Price TargetBuy$33.00 ➝ $27.00Low
i
4/7/2020CitigroupLower Price TargetNeutral$34.00 ➝ $25.00Low
i
4/3/2020Wells Fargo & CompanyLower Price TargetOverweight$32.00 ➝ $26.00Low
i
4/3/2020JPMorgan Chase & Co.Lower Price TargetOverweight$33.00 ➝ $27.00Low
i
Rating by Anthony Paolone at JPMorgan Chase & Co.
3/26/2020Morgan StanleyLower Price TargetEqual Weight$30.00 ➝ $24.00High
i
3/16/2020BTIG ResearchDowngradeBuy ➝ NeutralHigh
i
3/3/2020JPMorgan Chase & Co.Boost Price TargetOverweight$32.00 ➝ $33.00Low
i
Rating by Anthony Paolone at JPMorgan Chase & Co.
2/20/2020CitigroupBoost Price TargetNeutral$31.00 ➝ $34.00Medium
i
1/7/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$33.00 ➝ $35.00Low
i
12/20/2019MizuhoReiterated RatingBuy$35.00Low
i
12/18/2019JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$31.00 ➝ $32.00Low
i
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$30.00 ➝ $33.00High
i
10/29/2019CfraDowngradeBuy ➝ HoldMedium
i
10/29/2019BMO Capital MarketsReiterated RatingHold$28.00Low
i
9/12/2019Berenberg BankInitiated CoverageBuy$33.00Medium
i
6/20/2019CitigroupInitiated CoverageNeutral ➝ Neutral$29.00Low
i
5/13/2019Raymond JamesUpgradeMarket Perform ➝ OutperformMedium
i
4/10/2019SunTrust BanksLower Price TargetBuy$30.00Medium
i
3/29/2019Jefferies Financial GroupUpgradeHold ➝ Buy$30.00 ➝ $33.00Medium
i
3/28/2019Morgan StanleySet Price TargetHold$29.00Low
i
Rating by Vikram Malhorta at Morgan Stanley
2/15/2019Capital One FinancialUpgradeEqual Weight ➝ OverweightMedium
i
Rating by D. Bernstein at Capital One Financial Co.
2/14/2019BMO Capital MarketsReiterated RatingHold$28.00Medium
i
1/9/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$30.00 ➝ $28.00Low
i
12/13/2018Jefferies Financial GroupDowngradeBuy ➝ HoldMedium
i
11/13/2018MizuhoUpgradeNeutral ➝ Buy$32.00Low
i
10/29/2018SunTrust BanksLower Price TargetBuy ➝ Buy$32.00 ➝ $30.00Low
i
8/29/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$28.00 ➝ $29.00Low
i
8/16/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$27.00 ➝ $26.00Medium
i
8/13/2018Jefferies Financial GroupReiterated RatingBuy$34.00Low
i
7/10/2018Mitsubishi UFJ Financial GroupReiterated RatingOverweight ➝ Neutral$30.00 ➝ $28.00Low
i
Rating by K. Ford at Mitsubishi UFJ Financial Group
6/14/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$30.00 ➝ $27.00Low
i
6/1/2018Raymond JamesReiterated RatingMarket PerformLow
i
Rating by Jonathan Hughes at Raymond James
5/21/2018Raymond JamesDowngradeOutperform ➝ Market PerformLow
i
Rating by Jonathan Hughes at Raymond James
4/24/2018Stifel NicolausDowngradeBuy ➝ HoldMedium
i
Rating by Chad Vanacore at Stifel Nicolaus
3/26/2018BMO Capital MarketsSet Price TargetBuy$31.00Low
i
Rating by John Kim at BMO Capital Markets
3/26/2018Jefferies Financial GroupReiterated RatingBuy$32.00Low
i
3/20/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$33.00 ➝ $30.00Medium
i
2/27/2018Raymond JamesDowngradeStrong-Buy ➝ Outperform$34.00 ➝ $30.00Low
i
2/23/2018Jefferies Financial GroupReiterated RatingBuyLow
i
2/20/2018MizuhoDowngradeBuy ➝ Neutral$32.00Medium
i
2/16/2018Stifel NicolausLower Price TargetHold ➝ Hold$35.00 ➝ $32.00High
i
Rating by Chad Vanacore at Stifel Nicolaus
1/22/2018SunTrust BanksSet Price TargetBuy$33.00Low
i
Rating by Eric Fleming at SunTrust Banks, Inc.
1/9/2018BMO Capital MarketsReiterated RatingBuy$33.00Medium
i
12/13/2017Morgan StanleyUpgradeEqual Weight ➝ OverweightLow
i
10/29/2017Mitsubishi UFJ Financial GroupReiterated RatingOverweightN/A
i
Rating by K. Ford at Mitsubishi UFJ Financial Group
10/25/2017Stifel NicolausBoost Price TargetHold ➝ Hold$34.00 ➝ $35.00N/A
i
10/24/2017SunTrust BanksSet Price TargetBuy$36.00N/A
i
Rating by Eric Fleming at SunTrust Banks, Inc.
10/11/2017(FBRC)Set Price TargetHold$32.00N/A
i
Rating by C. Kucera at (FBRC)
10/4/2017MizuhoReiterated RatingBuy$36.00Low
i
10/3/2017Jefferies Financial GroupReiterated RatingBuy$34.00Low
i
10/2/2017BMO Capital MarketsReiterated RatingBuy$35.00Low
i
Rating by John Kim at BMO Capital Markets
9/25/2017Capital One FinancialReiterated RatingEqual Weight$31.00Low
i
Rating by D. Bernstein at Capital One Financial Co.
7/17/2017Raymond JamesUpgradeOutperform ➝ Strong-Buy$35.00Low
i
7/17/2017UBS GroupUpgradeOutperform ➝ Strong-BuyLow
i
7/12/2017Stifel NicolausLower Price TargetBuy$36.00 ➝ $34.00Low
i
7/11/2017(FBRC)Initiated CoverageMkt Perform$32.00Low
i
Rating by C. Kucera at (FBRC)
6/27/2017MizuhoReiterated RatingBuyMedium
i
6/20/2017BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$33.00 ➝ $35.00Low
i
Rating by John Kim at BMO Capital Markets
6/16/2017Wells Fargo & CompanyReiterated RatingOutperform$33.50 ➝ $35.00Low
i
6/5/2017Jefferies Financial GroupUpgradeBuy$36.00Low
i
5/15/2017BMO Capital MarketsSet Price TargetHold$33.00Low
i
Rating by John Kim at BMO Capital Markets
5/4/2017(MTU)Reiterated RatingBuyMedium
i
5/3/2017Mitsubishi UFJ Financial GroupReiterated RatingBuyHigh
i
Rating by Karin Ford at Mitsubishi UFJ Financial Group
5/1/2017Jefferies Financial GroupBoost Price TargetBuy$35.00 ➝ $36.00High
i
4/12/2017BMO Capital MarketsReiterated RatingHold$33.00Low
i
1/4/2017MizuhoUpgradeNeutral ➝ Buy$29.00 ➝ $32.00N/A
i
12/16/2016Jefferies Financial GroupInitiated CoverageBuy$33.00N/A
i
11/7/2016Raymond JamesUpgradeMarket Perform ➝ Outperform$33.00N/A
i
11/7/2016UBS GroupUpgradeMarket Perform ➝ OutperformN/A
i
8/25/2016BTIG ResearchInitiated CoverageBuy$37.00N/A
i
8/8/2016MizuhoLower Price TargetNeutral$34.00 ➝ $28.00N/A
i
8/3/2016WunderlichBoost Price TargetHold$28.50 ➝ $31.00N/A
i
Rating by Craig Kucera at Wunderlich
8/2/2016OppenheimerBoost Price TargetOutperform$37.00 ➝ $38.00N/A
i
4/27/2016WunderlichReiterated RatingHold$25.00 ➝ $28.50N/A
i
4/26/2016Stifel NicolausBoost Price TargetBuy$29.00 ➝ $31.00N/A
i
Rating by Daniel Bernstein at Stifel Nicolaus
3/23/2016BMO Capital MarketsBoost Price TargetMarket Perform$29.00N/A
i
3/21/2016SunTrust BanksInitiated CoverageBuy$32.00N/A
i
2/22/2016MizuhoBoost Price TargetNeutral$26.00 ➝ $28.00N/A
i
(Data available from 1/20/2016 forward)
Healthcare Trust of America logo
Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 25.1 million square feet of GLA, with $7.4 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the US REIT index.
Read More

Today's Range

Now: $28.80
$27.94
$29.09

50 Day Range

MA: $26.96
$25.72
$28.59

52 Week Range

Now: $28.80
$20.61
$34.22

Volume

1,180,573 shs

Average Volume

2,398,079 shs

Market Capitalization

$6.29 billion

P/E Ratio

192.00

Dividend Yield

4.54%

Beta

0.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Healthcare Trust of America?

The following Wall Street sell-side analysts have issued research reports on Healthcare Trust of America in the last year: BMO Capital Markets, BTIG Research, Capital One Financial Co., Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Raymond James, Smith Barney Citigroup, Stifel Nicolaus, SunTrust Banks, Inc., Wells Fargo & Company, and Zacks Investment Research.

What is the current price target for Healthcare Trust of America?

10 Wall Street analysts have set twelve-month price targets for Healthcare Trust of America in the last year. Their average twelve-month price target is $29.70, suggesting a possible upside of 4.6%. BMO Capital Markets has the highest price target set, predicting HTA will reach $38.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $24.00 for Healthcare Trust of America in the next year.

What is the current consensus analyst rating for Healthcare Trust of America?

Healthcare Trust of America currently has 5 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HTA will outperform the market and that investors should add to their positions of Healthcare Trust of America.

What other companies compete with Healthcare Trust of America?

How do I contact Healthcare Trust of America's investor relations team?

Healthcare Trust of America's physical mailing address is 16435 N. SCOTTSDALE ROAD SUITE 320, SCOTTSDALE AZ, 85254. The real estate investment trust's listed phone number is 480-998-3478 and its investor relations email address is info@htareit.com. The official website for Healthcare Trust of America is www.htareit.com.